MHRA Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited)
Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited) Drug alert number: EL (23)A/13 Date issued: 30 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Briviact 75 mg film-coated tablets, PLPI 18716/0146 SNOMED Code: 37622711000001100 Batch number Expiry date [...]
The post MHRA Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited) appeared first on PSNC Website.
Recent Comments